A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
CompletedOBSERVATIONAL
Enrollment
866
Participants
Timeline
Start Date
Not specified
Study Completion Date
November 30, 2005
Conditions
Neutropenia
Trial Locations (1)
35294
Mary Ellen Bradley, Birmingham
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)